{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:04:40Z","timestamp":1777446280745,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabet-metabolism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.diabet.2013.07.002","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T19:45:34Z","timestamp":1380311134000},"page":"389-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus"],"prefix":"10.1016","volume":"39","author":[{"given":"J.-B.","family":"Echouffo-Tcheugui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.P.","family":"Kengne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2013.07.002_bib0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/diacare.29.01.06.dc05-0776","article-title":"Recent trends in cardiovascular complications among men and women with and without diabetes","volume":"29","author":"Booth","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0010","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.281.14.1291","article-title":"Diabetes and decline in heart disease mortality in US adults","volume":"281","author":"Gu","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2013.07.002_bib0015","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/CIRCULATIONAHA.106.658948","article-title":"Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study","volume":"115","author":"Fox","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2013.07.002_bib0020","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.292.20.2495","article-title":"Trends in cardiovascular complications of diabetes","volume":"292","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2013.07.002_bib0025","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2337\/diacare.21.7.1138","article-title":"Mortality in adults with and without diabetes in a national cohort of the US population, 1971\u20131993","volume":"21","author":"Gu","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0030","series-title":"National Diabetes Fact Sheet: National estimates and general information on diabetes and prediabetes in the United States","author":"Centers for Disease Control Prevention","year":"2010"},{"key":"10.1016\/j.diabet.2013.07.002_bib0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1464-5491.2008.02640.x","article-title":"Is diabetes a coronary risk equivalent? Systematic review and meta-analysis","volume":"26","author":"Bulugahapitiya","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2013.07.002_bib0040","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1157\/13111789","article-title":"[Is diabetes mellitus a coronary heart disease equivalent? Results of a meta-analysis of prospective studies]","volume":"60","author":"Gonzalez-Clemente","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.diabet.2013.07.002_bib0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2337\/diacare.29.02.06.dc05-1299","article-title":"Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors","volume":"29","author":"Howard","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2013.07.002_bib0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2013.07.002_bib0060","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2013.07.002_bib0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2013.07.002_bib0070","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2013.07.002_bib0075","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/heartjnl-2011-300734","article-title":"Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review","volume":"98","author":"van Dieren","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.diabet.2013.07.002_bib0080","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00125-010-1681-4","volume":"53","author":"Kengne","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2013.07.002_bib0085","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/CS20000335","article-title":"The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.diabet.2013.07.002_bib0090","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.STR.0000020091.07144.C7","article-title":"UKPDS 60 risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine","volume":"33","author":"Kothari","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.diabet.2013.07.002_bib0095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1741826710394270","article-title":"Contemporary model for cardiovascular risk prediction in people with type 2 diabetes","volume":"18","author":"Kengne","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehab"},{"key":"10.1016\/j.diabet.2013.07.002_bib0100","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2337\/dc09-1444","article-title":"Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the new zealand diabetes cohort study","volume":"33","author":"Elley","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0105","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.CIR.83.1.356","article-title":"An updated coronary risk profile. A statement for health professionals","volume":"83","author":"Anderson","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2013.07.002_bib0110","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2013.07.002_bib0115","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2013.07.002_bib0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1071\/HC12181","article-title":"New Zealand Diabetes Cohort Study cardiovascular risk score for people with Type 2 diabetes: validation in the PREDICT cohort","volume":"4","author":"Robinson","year":"2012","journal-title":"J Prim Health Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/hc0302.102575","article-title":"Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study","volume":"105","author":"Assmann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2013.07.002_bib0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.318.7176.101","article-title":"A simple computer program for guiding management of cardiovascular risk factors and prescribing","volume":"318","author":"Hingorani","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.diabet.2013.07.002_bib0135","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.diabet.2013.07.002_bib0140","first-page":"S1","volume":"80","author":"Joint British recommendations on prevention of coronary heart disease in clinical practice","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.diabet.2013.07.002_bib0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00149831-200412000-00013","article-title":"Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory?","volume":"11","author":"Stephens","year":"2004","journal-title":"Eur J Cardiovasc Prev Rehab"},{"key":"10.1016\/j.diabet.2013.07.002_bib0150","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5694\/j.1326-5377.2009.tb02343.x","article-title":"Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study","volume":"190","author":"Davis","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.diabet.2013.07.002_bib0155","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/dc08-1918","article-title":"Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC\u2013Norfolk Cohort","volume":"32","author":"Simmons","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0160","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.numecd.2010.02.022","article-title":"Risk for cardiovascular events in an Italian population of patients with type 2 diabetes","volume":"21","author":"Pellegrini","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.diabet.2013.07.002_bib0165","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/dc09-0745","article-title":"Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study","volume":"32","author":"van der Heijden","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0170","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1464-5491.2005.01494.x","article-title":"Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study","volume":"22","author":"Guzder","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2013.07.002_bib0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabet.2013.07.002_bib0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6823-12-12","article-title":"Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the translating research into action for diabetes (triad) study","volume":"12","author":"Lu","year":"2012","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.diabet.2013.07.002_bib0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2337\/diacare.27.1.277","article-title":"Comparative study of prognostic value for coronary disease risk between the U.K.\u00a0prospective diabetes study and Framingham models","volume":"27","author":"Protopsaltis","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0190","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00125-009-1454-0","article-title":"Cardiovascular risk assessment scores for people with diabetes: a systematic review","volume":"52","author":"Chamnan","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2013.07.002_bib0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","article-title":"The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years","volume":"22","author":"Coutinho","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0200","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2337\/diacare.19.12.1445","article-title":"Retinopathy predicts coronary heart disease events in NIDDM patients","volume":"19","author":"Miettinen","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0205","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2337\/dc06-0233","article-title":"Retinopathy predicts future cardiovascular events among type 2 diabetic patients: the Valpolicella Heart Diabetes Study","volume":"29","author":"Targher","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0210","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2337\/diacare.28.6.1383","article-title":"Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study","volume":"28","author":"van Hecke","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2013.07.002_bib0215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc06-1747","article-title":"Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women","volume":"30","author":"Juutilainen","year":"2007","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabet.2013.07.002_bib0220","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/heartjnl-2011-301246","article-title":"Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker","volume":"98","author":"Moons","year":"2012","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.diabet.2013.07.002_bib0225","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/heartjnl-2011-301247","article-title":"Risk prediction models: II. External validation, model updating, and impact assessment","volume":"98","author":"Moons","year":"2012","journal-title":"Heart"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363613001298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363613001298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:03:02Z","timestamp":1596585782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363613001298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1262363613001298"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2013.07.002","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2013.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}